Antibody-Based Therapeutics in Breast Cancer: Clinical and Translational Perspectives
Anna Balata, Katarzyna Pogoda · 2025
Read Antibody-Based Therapeutics in Breast Cancer: Clinical and Translational Perspectives by Anna Balata, Katarzyna Pogoda (2025) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-12821488.txt.
Description
Anna Balata and Katarzyna Pogoda review antibody-based drugs across all breast cancer types, in this 2025 paper. Breast cancer remains the most common cancer in women and a leading killer. Lab-made antibodies have changed its treatment in the last two decades.
Plain antibodies against the HER2 marker set the standard for one subtype. Immune checkpoint drugs opened immunotherapy for the hardest subtype. Antibody-drug pairs now ferry chemotherapy straight to tumor cells, with several named products in use. Two-target antibodies form the newest wave. The review weighs trial evidence, resistance routes, and side effects, and argues for care matched to each tumor's biology.
Catalog record
| CREATOR | Anna Balata, Katarzyna Pogoda |
|---|---|
| YEAR | 2025 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 32 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |